Loading…
Validation of albumin determined in urine with the HemoCue point-of-care analyser
Albumin concentrations persistently between 20 and 200 mg L in first morning spot urine or urine collected overnight, referred to as microalbuminuria, indicate incipient nephropathy in diabetes mellitus. This study validates a new point-of-care device, the HemoCue Urine Albumin analyser, for handlin...
Saved in:
Published in: | Scandinavian journal of clinical and laboratory investigation 2003, Vol.63 (2), p.119-126 |
---|---|
Main Author: | |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c432t-7b4e2f2f04450d3972709b0dabd1f3a8ae6f4afceec49179006c59c03974c79f3 |
---|---|
cites | cdi_FETCH-LOGICAL-c432t-7b4e2f2f04450d3972709b0dabd1f3a8ae6f4afceec49179006c59c03974c79f3 |
container_end_page | 126 |
container_issue | 2 |
container_start_page | 119 |
container_title | Scandinavian journal of clinical and laboratory investigation |
container_volume | 63 |
creator | VON SCHENCK, H. |
description | Albumin concentrations persistently between 20 and 200 mg L in first morning spot urine or urine collected overnight, referred to as microalbuminuria, indicate incipient nephropathy in diabetes mellitus. This study validates a new point-of-care device, the HemoCue Urine Albumin analyser, for handling, accuracy precision and predictive values (PV±) at 20 mg L. Over a period of 2 months, 200 microalbuminuria samples were selected at the Department of Clinical Chemistry according to the results from the Integra 700 instrument (Roche, R) and analysed on the same day using the HemoCue analyser (HemoCue, H) and the Immage instrument (Beckman, B), in all cases closely following the manufacturers' instructions. Only 137 results were within the measuring range of H, 10-150 mg L. Comparisons yielded regression lines H=1.06R-7.2 (r2=0.94), H=1.08B-3.1 (r2=0.94) and R=1.00B+4.3 (r2=0.99). Inter-assay (n=24) CV% at 12 mg L was H=18.2, R=4.2 and B=2.9 and at 65 mg L: H=6.1, R=1.8 and B=2.6. Intra-assay duplicate CV% for H at 21-40 mg L was 13.2, at 41-80 mg L 10.8 and at 81-150 mg L 9.2. Intra-assay repeatability (n=8) CV% at 28 mg L was 7.2-13.8, at 57 mg L 6.4-8.4 and at 105 mg L 4.3-7.1. External quality assurance urine albumin (B) was +5.7% cf. nephelometry and (R) +1.0% cf. turbidimetry (n=6) method-group means. PV± values were (H versus R) 0.98 0.37 and (H versus B) 0.95 0.65. HemoCue is easy to handle. Results below 20 mg L need to be confirmed at the central laboratory to exclude microalbuminuria. Values above 20 mg L can be used to follow microalbuminuria, as precision allows discerning steps of 10 mg L. |
doi_str_mv | 10.1080/00365510310000178 |
format | article |
fullrecord | <record><control><sourceid>proquest_infor</sourceid><recordid>TN_cdi_informaworld_taylorfrancis_310_1080_00365510310000178</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73273328</sourcerecordid><originalsourceid>FETCH-LOGICAL-c432t-7b4e2f2f04450d3972709b0dabd1f3a8ae6f4afceec49179006c59c03974c79f3</originalsourceid><addsrcrecordid>eNp9kNGK1DAUhoMo7rj6AN5IbvSuetKkTYveyKC7woII6m05TU-YLGkzJinLvL0ZZmSRhc1NTsj3_yQfY68FvBfQwQcA2TaNACmgLKG7J2wjGqgr3XbtU7Y53lcFkBfsRUq3hZGyU8_Zhah1I9pebtiP3-jdhNmFhQfL0Y_r7BY-UaZYBpp4Oa2xTPzO5R3PO-LXNIftSnwf3JKrYCuDkTgu6A-J4kv2zKJP9Oq8X7JfX7_83F5XN9-vvm0_31RGyTpXelRU29qCUg1Mste1hn6ECcdJWIkdUmsVWkNkVC90D9CapjdQSGV0b-Ule3fq3cfwZ6WUh9klQ97jQmFNg5a1lrLuCihOoIkhpUh22Ec3YzwMAoajx-GBx5J5cy5fx5mm-8RZXAHengFMBr2NuBiX7jmlewXyWPTpxLnFhjjjXYh-GjIefIj_QvKxd3z8L74j9Hl39D3chjUW5emRX_wFWgefEg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73273328</pqid></control><display><type>article</type><title>Validation of albumin determined in urine with the HemoCue point-of-care analyser</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>VON SCHENCK, H.</creator><creatorcontrib>VON SCHENCK, H.</creatorcontrib><description>Albumin concentrations persistently between 20 and 200 mg L in first morning spot urine or urine collected overnight, referred to as microalbuminuria, indicate incipient nephropathy in diabetes mellitus. This study validates a new point-of-care device, the HemoCue Urine Albumin analyser, for handling, accuracy precision and predictive values (PV±) at 20 mg L. Over a period of 2 months, 200 microalbuminuria samples were selected at the Department of Clinical Chemistry according to the results from the Integra 700 instrument (Roche, R) and analysed on the same day using the HemoCue analyser (HemoCue, H) and the Immage instrument (Beckman, B), in all cases closely following the manufacturers' instructions. Only 137 results were within the measuring range of H, 10-150 mg L. Comparisons yielded regression lines H=1.06R-7.2 (r2=0.94), H=1.08B-3.1 (r2=0.94) and R=1.00B+4.3 (r2=0.99). Inter-assay (n=24) CV% at 12 mg L was H=18.2, R=4.2 and B=2.9 and at 65 mg L: H=6.1, R=1.8 and B=2.6. Intra-assay duplicate CV% for H at 21-40 mg L was 13.2, at 41-80 mg L 10.8 and at 81-150 mg L 9.2. Intra-assay repeatability (n=8) CV% at 28 mg L was 7.2-13.8, at 57 mg L 6.4-8.4 and at 105 mg L 4.3-7.1. External quality assurance urine albumin (B) was +5.7% cf. nephelometry and (R) +1.0% cf. turbidimetry (n=6) method-group means. PV± values were (H versus R) 0.98 0.37 and (H versus B) 0.95 0.65. HemoCue is easy to handle. Results below 20 mg L need to be confirmed at the central laboratory to exclude microalbuminuria. Values above 20 mg L can be used to follow microalbuminuria, as precision allows discerning steps of 10 mg L.</description><identifier>ISSN: 0036-5513</identifier><identifier>EISSN: 1502-7686</identifier><identifier>DOI: 10.1080/00365510310000178</identifier><identifier>PMID: 12751693</identifier><identifier>CODEN: SJCLAY</identifier><language>eng</language><publisher>Oslo: Informa UK Ltd</publisher><subject>Albumin-discerning steps ; Albuminuria - urine ; Biological and medical sciences ; Chemistry, Clinical - instrumentation ; Chemistry, Clinical - methods ; Chemistry, Clinical - standards ; decision limit ; diabetes mellitus ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Medical sciences ; Outpatients ; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques ; Point-of-Care Systems ; Predictive Value of Tests ; predictive values ; quality assurance ; Quality Assurance, Health Care ; Reproducibility of Results ; urinary albumin ; Urinary system</subject><ispartof>Scandinavian journal of clinical and laboratory investigation, 2003, Vol.63 (2), p.119-126</ispartof><rights>2003 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2003</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c432t-7b4e2f2f04450d3972709b0dabd1f3a8ae6f4afceec49179006c59c03974c79f3</citedby><cites>FETCH-LOGICAL-c432t-7b4e2f2f04450d3972709b0dabd1f3a8ae6f4afceec49179006c59c03974c79f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14794038$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12751693$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>VON SCHENCK, H.</creatorcontrib><title>Validation of albumin determined in urine with the HemoCue point-of-care analyser</title><title>Scandinavian journal of clinical and laboratory investigation</title><addtitle>Scand J Clin Lab Invest</addtitle><description>Albumin concentrations persistently between 20 and 200 mg L in first morning spot urine or urine collected overnight, referred to as microalbuminuria, indicate incipient nephropathy in diabetes mellitus. This study validates a new point-of-care device, the HemoCue Urine Albumin analyser, for handling, accuracy precision and predictive values (PV±) at 20 mg L. Over a period of 2 months, 200 microalbuminuria samples were selected at the Department of Clinical Chemistry according to the results from the Integra 700 instrument (Roche, R) and analysed on the same day using the HemoCue analyser (HemoCue, H) and the Immage instrument (Beckman, B), in all cases closely following the manufacturers' instructions. Only 137 results were within the measuring range of H, 10-150 mg L. Comparisons yielded regression lines H=1.06R-7.2 (r2=0.94), H=1.08B-3.1 (r2=0.94) and R=1.00B+4.3 (r2=0.99). Inter-assay (n=24) CV% at 12 mg L was H=18.2, R=4.2 and B=2.9 and at 65 mg L: H=6.1, R=1.8 and B=2.6. Intra-assay duplicate CV% for H at 21-40 mg L was 13.2, at 41-80 mg L 10.8 and at 81-150 mg L 9.2. Intra-assay repeatability (n=8) CV% at 28 mg L was 7.2-13.8, at 57 mg L 6.4-8.4 and at 105 mg L 4.3-7.1. External quality assurance urine albumin (B) was +5.7% cf. nephelometry and (R) +1.0% cf. turbidimetry (n=6) method-group means. PV± values were (H versus R) 0.98 0.37 and (H versus B) 0.95 0.65. HemoCue is easy to handle. Results below 20 mg L need to be confirmed at the central laboratory to exclude microalbuminuria. Values above 20 mg L can be used to follow microalbuminuria, as precision allows discerning steps of 10 mg L.</description><subject>Albumin-discerning steps</subject><subject>Albuminuria - urine</subject><subject>Biological and medical sciences</subject><subject>Chemistry, Clinical - instrumentation</subject><subject>Chemistry, Clinical - methods</subject><subject>Chemistry, Clinical - standards</subject><subject>decision limit</subject><subject>diabetes mellitus</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Medical sciences</subject><subject>Outpatients</subject><subject>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</subject><subject>Point-of-Care Systems</subject><subject>Predictive Value of Tests</subject><subject>predictive values</subject><subject>quality assurance</subject><subject>Quality Assurance, Health Care</subject><subject>Reproducibility of Results</subject><subject>urinary albumin</subject><subject>Urinary system</subject><issn>0036-5513</issn><issn>1502-7686</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNp9kNGK1DAUhoMo7rj6AN5IbvSuetKkTYveyKC7woII6m05TU-YLGkzJinLvL0ZZmSRhc1NTsj3_yQfY68FvBfQwQcA2TaNACmgLKG7J2wjGqgr3XbtU7Y53lcFkBfsRUq3hZGyU8_Zhah1I9pebtiP3-jdhNmFhQfL0Y_r7BY-UaZYBpp4Oa2xTPzO5R3PO-LXNIftSnwf3JKrYCuDkTgu6A-J4kv2zKJP9Oq8X7JfX7_83F5XN9-vvm0_31RGyTpXelRU29qCUg1Mste1hn6ECcdJWIkdUmsVWkNkVC90D9CapjdQSGV0b-Ule3fq3cfwZ6WUh9klQ97jQmFNg5a1lrLuCihOoIkhpUh22Ec3YzwMAoajx-GBx5J5cy5fx5mm-8RZXAHengFMBr2NuBiX7jmlewXyWPTpxLnFhjjjXYh-GjIefIj_QvKxd3z8L74j9Hl39D3chjUW5emRX_wFWgefEg</recordid><startdate>2003</startdate><enddate>2003</enddate><creator>VON SCHENCK, H.</creator><general>Informa UK Ltd</general><general>Taylor & Francis</general><general>Scandinavian University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2003</creationdate><title>Validation of albumin determined in urine with the HemoCue point-of-care analyser</title><author>VON SCHENCK, H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c432t-7b4e2f2f04450d3972709b0dabd1f3a8ae6f4afceec49179006c59c03974c79f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Albumin-discerning steps</topic><topic>Albuminuria - urine</topic><topic>Biological and medical sciences</topic><topic>Chemistry, Clinical - instrumentation</topic><topic>Chemistry, Clinical - methods</topic><topic>Chemistry, Clinical - standards</topic><topic>decision limit</topic><topic>diabetes mellitus</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Medical sciences</topic><topic>Outpatients</topic><topic>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</topic><topic>Point-of-Care Systems</topic><topic>Predictive Value of Tests</topic><topic>predictive values</topic><topic>quality assurance</topic><topic>Quality Assurance, Health Care</topic><topic>Reproducibility of Results</topic><topic>urinary albumin</topic><topic>Urinary system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>VON SCHENCK, H.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Scandinavian journal of clinical and laboratory investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>VON SCHENCK, H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Validation of albumin determined in urine with the HemoCue point-of-care analyser</atitle><jtitle>Scandinavian journal of clinical and laboratory investigation</jtitle><addtitle>Scand J Clin Lab Invest</addtitle><date>2003</date><risdate>2003</risdate><volume>63</volume><issue>2</issue><spage>119</spage><epage>126</epage><pages>119-126</pages><issn>0036-5513</issn><eissn>1502-7686</eissn><coden>SJCLAY</coden><abstract>Albumin concentrations persistently between 20 and 200 mg L in first morning spot urine or urine collected overnight, referred to as microalbuminuria, indicate incipient nephropathy in diabetes mellitus. This study validates a new point-of-care device, the HemoCue Urine Albumin analyser, for handling, accuracy precision and predictive values (PV±) at 20 mg L. Over a period of 2 months, 200 microalbuminuria samples were selected at the Department of Clinical Chemistry according to the results from the Integra 700 instrument (Roche, R) and analysed on the same day using the HemoCue analyser (HemoCue, H) and the Immage instrument (Beckman, B), in all cases closely following the manufacturers' instructions. Only 137 results were within the measuring range of H, 10-150 mg L. Comparisons yielded regression lines H=1.06R-7.2 (r2=0.94), H=1.08B-3.1 (r2=0.94) and R=1.00B+4.3 (r2=0.99). Inter-assay (n=24) CV% at 12 mg L was H=18.2, R=4.2 and B=2.9 and at 65 mg L: H=6.1, R=1.8 and B=2.6. Intra-assay duplicate CV% for H at 21-40 mg L was 13.2, at 41-80 mg L 10.8 and at 81-150 mg L 9.2. Intra-assay repeatability (n=8) CV% at 28 mg L was 7.2-13.8, at 57 mg L 6.4-8.4 and at 105 mg L 4.3-7.1. External quality assurance urine albumin (B) was +5.7% cf. nephelometry and (R) +1.0% cf. turbidimetry (n=6) method-group means. PV± values were (H versus R) 0.98 0.37 and (H versus B) 0.95 0.65. HemoCue is easy to handle. Results below 20 mg L need to be confirmed at the central laboratory to exclude microalbuminuria. Values above 20 mg L can be used to follow microalbuminuria, as precision allows discerning steps of 10 mg L.</abstract><cop>Oslo</cop><pub>Informa UK Ltd</pub><pmid>12751693</pmid><doi>10.1080/00365510310000178</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0036-5513 |
ispartof | Scandinavian journal of clinical and laboratory investigation, 2003, Vol.63 (2), p.119-126 |
issn | 0036-5513 1502-7686 |
language | eng |
recordid | cdi_informaworld_taylorfrancis_310_1080_00365510310000178 |
source | Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list) |
subjects | Albumin-discerning steps Albuminuria - urine Biological and medical sciences Chemistry, Clinical - instrumentation Chemistry, Clinical - methods Chemistry, Clinical - standards decision limit diabetes mellitus Humans Investigative techniques, diagnostic techniques (general aspects) Medical sciences Outpatients Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques Point-of-Care Systems Predictive Value of Tests predictive values quality assurance Quality Assurance, Health Care Reproducibility of Results urinary albumin Urinary system |
title | Validation of albumin determined in urine with the HemoCue point-of-care analyser |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T10%3A19%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Validation%20of%20albumin%20determined%20in%20urine%20with%20the%20HemoCue%20point-of-care%20analyser&rft.jtitle=Scandinavian%20journal%20of%20clinical%20and%20laboratory%20investigation&rft.au=VON%20SCHENCK,%20H.&rft.date=2003&rft.volume=63&rft.issue=2&rft.spage=119&rft.epage=126&rft.pages=119-126&rft.issn=0036-5513&rft.eissn=1502-7686&rft.coden=SJCLAY&rft_id=info:doi/10.1080/00365510310000178&rft_dat=%3Cproquest_infor%3E73273328%3C/proquest_infor%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c432t-7b4e2f2f04450d3972709b0dabd1f3a8ae6f4afceec49179006c59c03974c79f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=73273328&rft_id=info:pmid/12751693&rfr_iscdi=true |